Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$108.1M-16.8%$164.9M+32.8%$120.9M-26.1%$116.5M+19.4%$129.9M+86.1%
$30M-12.8%$45.8M+6.8%$31.7M-21.1%$45.7M+8.0%$34.4M-14.4%
-$93.2M-3,314%-$34.2M-12.1%-$43M+22.8%-$115.4M-273%$2.9M+107%
$47.8M-53.1%$0$53.4M-45.5%$140.2M+38.8%$101.9M+2,068%
$100K0.0%$200K$0-100%$200K+100%$100K-50.0%
-$44M+55.0%$0+100%-$52.5M+45.3%-$136.3M-41.1%-$97.7M
-$23.2M-170%$134M+72.7%$26.5M+489%-$151.4M$33.3M+13.3%
$78.1M-18.2%$119.1M+46.5%$89.2M-27.7%$70.8M+28.0%$95.5M+223%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Bio-Rad Laboratories, Inc. generate?
Bio-Rad Laboratories, Inc. (BIO.B) generated $510.4M in operating cash flow over the trailing twelve months.
What is Bio-Rad Laboratories, Inc.'s free cash flow?
After $153.2M of capital expenditures, Bio-Rad Laboratories, Inc.'s free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
Where does Bio-Rad Laboratories, Inc.'s cash flow data come from?
Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.